Search results
Found 29538 matches for
Welcome to our viewers from IF: Oxford. We've put all our family friendly resources on the Oxford Biopatch in this blog post. Do let us know if you have a go at the crafting activities described at the end of this page.
Climax Research Professor of Regulatory Science (175665)
NDORMS Research scientists
The candidate for this leadership position should be an internationally recognised authority who has practical experience in the regulation of medical and healthcare products; qualified in a relevant legal, scientific or biomedical discipline, with substantial legal/regulatory practice experience.
Clinical Trials Manager (175781)
Kadoorie NDORMS Research delivery
Taking overall responsibility for the day to day management of one or more clinical trials our clinical trials manager will assist in finalising the protocol, study materials, training packages for collaborating sites and prepare trial specific instructions.
Senior IT Analyst (2nd Line) (175484)
NDORMS Professional services
Help play a crucial part in supporting the valuable research and teaching activities across the NDORMS institutes: Botnar Institute for Musculoskeletal Sciences, Kennedy Institute of Rheumatology, and The Kadoorie Centre.
Research Grants Manager (Maternity cover or secondment) (175635)
Botnar Professional services
Combining line management responsibilities for a small team alongside directly managing a portfolio of research groups, you will be required to act as a financial guide, providing professional and flexible financial management to research groups, to support the achievement of the department’s strategic objectives.
Postdoctoral Researcher in Cell Assay Development and chemico-genomic Screening (175200)
Botnar NDORMS Research delivery
With demonstrable experience in molecular and cell biology techniques your role will be the development and adaptation of cell-based assays, execution of chemical and genetic screening and identification of mode of action of identified hits that could constitute novel targets in MSK diseases.